Iran Reveals COVID-19 Data For October 10
Date
10/11/2022 2:21:28 AM
(MENAFN- Trend News Agency)
BAKU, Azerbaijan, October 10. As many as 724
people have been infected with the coronavirus (COVID-19) in the
past 24 hours in Iran, reads the statement of the Ministry of
Health and Medical Education of Iran, reports.
In addition, 4 people have died from the coronavirus over the
past day.
At the same time, the condition of 124 people remains
critical.
So far, more than 54.1 million tests have been conducted in Iran
for the diagnosis of coronavirus.
In total, about 155 million doses of vaccines have been used in
Iran so far. A total of 65 million doses have been used in the
first stage, 58.5 million doses - in the second stage, and 31.2
million doses – in the third stage.
Iran continues to monitor the coronavirus situation in the
country. According to recent reports from Iranian officials, over
7.55 million people have been infected, and 144,490 people have
already died.
Meanwhile, over 7.32 million people have reportedly recovered
from the disease. The country continues to apply strict measures to
contain the further spread of the virus.
Reportedly, the disease was brought to Iran by a businessman
from Iran's Qom city, who went on a business trip to China, despite
official warnings. The man died later from the disease. The Islamic
Republic announced its first infections and deaths from the
coronavirus on Feb. 19.
The outbreak in the Chinese city of Wuhan - which is an
international transport hub - began at a fish market in late
December 2019.
The World Health Organization (WHO) on March 11 declared
COVID-19 a pandemic. Some sources claim the coronavirus outbreak
started as early as November 2019.
---
Follow the author on Twitter:
MENAFN11102022000187011040ID1104999118
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.